Christopher Bowden
Director/Miembro de la Junta en Cedilla Therapeutics, Inc. .
Perfil
Christopher J.
Bowden currently works at Cedilla Therapeutics, Inc., as Director from 2021.
Dr. Bowden also formerly worked at Bristol Myers Squibb Co., as Executive Director-Europe, Middle East & Africa from 2003 to 2006, Alaunos Therapeutics, Inc., as Independent Director from 2019 to 2023, Viridian Therapeutics, Inc., as Independent Director from 2017 to 2020, Genentech, Inc., as VP-Product Development Oncology from 2006 to 2014, Agios Pharmaceuticals, Inc., as Chief Medical Officer from 2014 to 2021, and Roche Group, as Member from 2006 to 2014.
Dr. Bowden received his undergraduate degree from Lake Forest College and doctorate degree in 1988 from Drexel University College of Medicine.
Cargos activos de Christopher Bowden
| Empresas | Cargo | Inicio |
|---|---|---|
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 21/04/2021 |
Antiguos cargos conocidos de Christopher Bowden.
| Empresas | Cargo | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 30/03/2023 |
| AGIOS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/09/2021 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/10/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2014 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2014 |
Formación de Christopher Bowden.
| Drexel University College of Medicine | Doctorate Degree |
| Lake Forest College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Bowden
